Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. 1999

M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. mostrowski@nih.gov

Cellular activation is critical for the propagation of human immunodeficiency virus type 1 (HIV-1) infection. It has been suggested that truly naive CD4(+) T cells are resistant to productive HIV-1 infection because of their constitutive resting state. Memory and naive CD4(+) T-cell subsets from 11 HIV-1-infected individuals were isolated ex vivo by a combination of magnetic bead depletion and fluorescence-activated cell sorting techniques with stringent criteria of combined expression of CD45RA and CD62L to identify naive CD4(+) T-cell subsets. In all patients HIV-1 provirus could be detected within naive CD45RA+/CD62L+ CD4(+) T cells; in addition, replication-competent HIV-1 was isolated from these cells upon CD4(+) T-cell stimulation in tissue cultures. Memory CD4(+) T cells had a median of fourfold more replication-competent virus and a median of sixfold more provirus than naive CD4(+) T cells. Overall, there was a median of 16-fold more integrated provirus identified in memory CD4(+) T cells than in naive CD4(+) T cells within a given patient. Interestingly, there was a trend toward equalization of viral loads in memory and naive CD4(+) T-cell subsets in those patients who harbored CXCR4-using (syncytium-inducing) viruses. Within any given patient, there was no selective usage of a particular coreceptor by virus isolated from memory versus naive CD4(+) T cells. Our findings suggest that naive CD4(+) T cells may be a significant viral reservoir for HIV, particularly in those patients harboring CXCR4-using viruses.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015699 HIV Envelope Protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Envelope Glycoprotein gp120, HIV,HTLV-III gp120,env Protein gp120, HIV,gp120(HIV),HIV Envelope Glycoprotein gp120,gp120 Envelope Glycoprotein, HIV,HTLV III gp120,gp120, HTLV-III
D016176 T-Lymphocyte Subsets A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Cell Subset,T-Cell Subsets,T-Lymphocyte Subset,Subset, T-Cell,Subset, T-Lymphocyte,Subsets, T-Cell,Subsets, T-Lymphocyte,T Cell Subset,T Cell Subsets,T Lymphocyte Subset,T Lymphocyte Subsets

Related Publications

M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
July 1993, The American review of respiratory disease,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
December 2010, The Journal of infectious diseases,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
April 2004, AIDS (London, England),
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
January 1990, Disease markers,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
May 1989, Proceedings of the National Academy of Sciences of the United States of America,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
November 1995, Journal of virology,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
April 2012, The Journal of experimental medicine,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
January 2003, Arthritis research & therapy,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
March 1999, AIDS research and human retroviruses,
M A Ostrowski, and T W Chun, and S J Justement, and I Motola, and M A Spinelli, and J Adelsberger, and L A Ehler, and S B Mizell, and C W Hallahan, and A S Fauci
January 2006, Journal of virology,
Copied contents to your clipboard!